Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Rainer, BM; Kang, S; Chien, AL.
Rosacea: Epidemiology, pathogenesis, and treatment.
Dermatoendocrinol. 2017; 9(1):e1361574-e1361574
Doi: 10.1080/19381980.2017.1361574
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Rainer Barbara
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Rosacea is a chronic relapsing inflammatory skin disease with a high prevalence among adults of Northern European heritage with fair skin. Symptoms present in various combinations and severity, often fluctuating between periods of exacerbation and remission. Based on morphological characteristics, rosacea is generally classified into four major subtypes: erythematotelangiectatic, papulopustular, phymatous, and ocular. Diverse environmental and endogenous factors have been shown to stimulate an augmented innate immune response and neurovascular dysregulation; however, rosacea's exact pathogenesis is still unclear. An evidence-based approach is essential in delineating differences between the many available treatments. Because of the diverse presentations of rosacea, approaches to treatment must be individualized based on the disease severity, quality-of-life implications, comorbidities, trigger factors, and the patient's commitment to therapy.
- Find related publications in this database (Keywords)
-
comorbidities
-
genetics
-
innate immunity
-
management
-
neurovascular dysregulation
-
prevalence
-
quality-of-life